Surface Oncology, Inc.
SURFDelisted Sep 8, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001718108
Surface Oncology, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Sep 8, 2023; 62 institutions reported holding it in 13F filings for Q2 2023, worth $16.9M in total; ARK Invest was the only superinvestor holding it.
13F holders, Q4 2021
Institutional positions in Surface Oncology, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 107
- +16 vs. Q3 2021
- Shares held
- 24.7M
- +644.4K (+2.7%) vs. Q3 2021
- Total value
- $118.0M
- −$63.9M (−35.1%) vs. Q3 2021
- New holders
- 25
- 32 more added
- Sold out
- 9
- 31 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SURF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $21.0K |
| Q3 2025 | 1 | $21.0K |
| Q2 2025 | 1 | $21.0K |
| Q1 2025 | 1 | $21.0K |
| Q4 2024 | 1 | $21.0K |
| Q3 2024 | 1 | $21.0K |
| Q2 2024 | 1 | $21.0K |
| Q1 2024 | 1 | $21.0K |
| Q4 2023 | 1 | $21.0K |
| Q3 2023 | 2 | $21.3K |
| Q2 2023 | 62 | $16.9M |
| Q1 2023 | 72 | $18.8M |
| Q4 2022 | 80 | $23.4M |
| Q3 2022 | 80 | $32.8M |
| Q2 2022 | 85 | $48.6M |
| Q1 2022 | 104 | $93.8M |
| Q4 2021 | 107 | $118.0M |
| Q3 2021 | 92 | $182.2M |
| Q2 2021 | 97 | $168.5M |
| Q1 2021 | 91 | $147.5M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Surface Oncology, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 1,442,036 | $6.89M | 0.01% | −15,607−1.1% | Reduced |
| Vanguard Group Inc | 1,459,905 | $6.98M | 0.00% | +250,684+20.7% | Added |
| BlackRock Inc. | 2,562,685 | $12.3M | 0.00% | +137,742+5.7% | Added |
| Atlas Venture Associates IX, LLC | 2,945,453 | $14.1M | 6.15% | 00.0% | Unchanged |
| ARK Investment Management LLCSuperinvestorARK Invest | 5,326,127 | $25.5M | 0.08% | +707,773+15.3% | Added |
| Federated Hermes, Inc. | 3 | – | – | +3 | New |
| Edge Wealth Management LLC | 50 | – | – | +50 | New |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −232,162−100.0% | Sold out |
| Summit Global Investments | 0 | $0 | 0.00% | −56,549−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −26,650−100.0% | Sold out |
| NinePointTwo Capital | 0 | $0 | 0.00% | −16,206−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −13,932−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Ausdal Financial Partners, Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −1,040−100.0% | Sold out |
| Marshall Wace North America L.P. | – | – | – | – | Not filed |